Mary Dolan to Germ-Line Mutation
This is a "connection" page, showing publications Mary Dolan has written about Germ-Line Mutation.
Connection Strength
0.500
-
Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:775-786.
Score: 0.448
-
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
Score: 0.032
-
Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet. 2013 Jan; 14(1):23-34.
Score: 0.019